TMO Earnings
Latest Revenue12.0B
Latest Net Income1.7B
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $4.68 | 12.0B | 1.7B | +10.5% | +9.3% |
| Q1 2026 | $4.44 | 11.0B | 1.7B | +6.2% | +11.3% |
| Q4 2025 | $5.25 | 12.2B | 2.0B | +7.2% | +9.6% |
| Q3 2025 | $4.28 | 11.1B | 1.6B | +4.9% | +0.5% |
| Q2 2025 | $4.28 | 10.9B | 1.6B | +3.0% | +5.7% |
| Q1 2025 | $3.99 | 10.4B | 1.5B | +0.2% | +15.0% |
| Q4 2024 | $4.79 | 11.4B | 1.8B | +4.7% | +13.5% |
| Q3 2024 | $4.26 | 10.6B | 1.6B | +0.2% | -4.1% |
| Q2 2024 | $4.05 | 10.5B | 1.6B | — | — |
| Q1 2024 | $3.47 | 10.3B | 1.3B | — | — |
| Q4 2023 | $4.22 | 10.9B | 1.6B | — | — |
| Q3 2023 | $4.44 | 10.6B | 1.7B | — | — |
Thermo Fisher Scientific (TMO) — Earnings